Innovations in Cancer Summer 2023
Showing of 3 results

New Study Published in NEJM Evidence with UH Seidman Cancer Center Researchers and ArteraAI
Study validates the first-ever predictive AI biomarker of androgen deprivation therapy (ADT) benefit in prostate cancer - Innovations in Cancer | Summer 2023

UH Seidman Oncologists Help Chart New Path for Advanced Melanoma Patients
Innovations in Cancer | Summer 2023

UH Seidman Team Identifies New Subgroup of Small Cell Lung Cancer
Clinical trial borne from new findings showing promising results - Innovations in Cancer | Summer 2023
Results are loading...